Target intelligence / Profile preview

Ubiquitin-like with PHD and ring finger domains 1 mRNA (UHRF1 mRNA)

Target
UHRF1 mRNA
Molecular classification
mRNA, Nucleic acid
01

Overview

Ubiquitin-like with PHD and ring finger domains 1 (UHRF1) mRNA encodes a multi-domain protein that plays a critical role in maintaining DNA methylation patterns during cell division (UniProt Q96T88) [1]. UHRF1 acts as a bridge between DNA methylation and histone modifications, specifically by recognizing hemi-methylated DNA and recruiting DNA methyltransferase 1 (DNMT1) to the replication fork (PMID: 27049015) [2]. In many human cancers, UHRF1 is significantly overexpressed, leading to the silencing of tumor suppressor genes through hypermethylation and contributing to genomic instability (PMID: 31110296) [3]. Targeting UHRF1 mRNA using antisense oligonucleotides or RNA interference represents a therapeutic strategy to deplete UHRF1 protein levels, thereby reactivating silenced tumor suppressors and inhibiting cancer cell proliferation (PMID: 23653361) [4]. While primarily studied in the context of oncology, the precise regulation of UHRF1 is essential for normal development, making selective targeting of cancerous cells a key challenge in drug development.

Other names
Np95 mRNAICBP90 mRNARNF106 mRNAUbiquitin-like-containing PHD and RING finger domains 1 mRNATranscription factor ICBP90 mRNA
02

Mechanism of action

Degradation of target mRNA via RNase H-mediated cleavage or RNA interference (RNAi) to prevent translation of the UHRF1 protein.

03

Biological functions

DNA methylation maintenanceHistone modificationCell cycle regulationEpigenetic regulationChromatin remodeling
04

Disease associations

CancerHepatocellular carcinomaBreast cancerLung cancerBladder cancerColorectal cancer
05

Safety considerations

Off-target effects on unintended mRNA transcriptsSystemic toxicity associated with delivery vehicles (e.g., lipid nanoparticles)Potential impact on normal proliferating stem cell populationsInduction of innate immune responses by synthetic oligonucleotides
06

Interacting drugs

Antisense oligonucleotides (ASOs)

1 more in the full profile.

07

Biomarkers

UHRF1 mRNA expression levelsUHRF1 protein levelsDNA methylation status of tumor suppressor genes (e.g., p16INK4A)Cell proliferation markers (e.g., Ki-67)

Beyond the preview

Go deeper on Ubiquitin-like with PHD and ring finger domains 1 mRNA (UHRF1 mRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ubiquitin-like with PHD and ring finger domains 1 mRNA (UHRF1 mRNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call